Adam10-flox Mouse
一般名
Adam10-flox
製品ID
S-CKO-18794
背景情報
C57BL/6NCya
系統ID
CKOCMP-11487-Adam10-B6N-VA
状況
このマウス系統を論文で使用する場合は、「Adam10-flox Mouse(カタログ番号S-CKO-18794)はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Adam10-flox
系統ID
CKOCMP-11487-Adam10-B6N-VA
遺伝子名
製品ID
S-CKO-18794
遺伝子別名
kuz, MADM, kuzbanian, 1700031C13Rik
遺伝子別名
C57BL/6NCya
NCBI ID
修正
Conditional knockout
染色体
Chr 9
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000067880
NCBIトランスクリプトID
NM_007399
ターゲット領域
Exon 7~8
有効領域の大きさ
~3.2 kb
遺伝子研究の概要
ADAM10, a member of the ADAM superfamily, is a membrane-bound protein with a catalytic domain on the cell surface. It functions as a sheddase, cleaving over 100 anchored cell-surface proteins, and is involved in diverse cellular processes such as cell adhesion, migration, and proteolysis. ADAM10 is best known for its role in the Notch signaling pathway. It is expressed in most tissues of the body and is crucial for mammalian development, physiology, and non-amyloidogenic cleavage of APP as the primary α-secretase [1,2,3].
In hair follicles, ablation of the ADAM10-Notch signaling axis in mouse models impaired the innate epithelial barrier, led to skin dysbiosis, and ultimately caused hair follicle destruction due to inflammation [4]. In the context of cancer, ADAM10 cleavage of Trop-2 was shown to act as an activator switch for cancer growth and metastasis, and ADAM10 also modulates the efficacy of T-cell-mediated therapy in solid tumors [5,6]. In Alzheimer's disease, lower levels of ADAM10 were found in platelets of AD patients, while higher levels were seen in plasma, and CSF results were controversial, indicating its potential as a biomarker [7].
In conclusion, ADAM10 is a multifunctional protein involved in various biological processes and diseases. Studies using mouse models have revealed its role in maintaining tissue integrity, such as in hair follicles, and its implications in cancer progression and Alzheimer's disease, highlighting its potential as a therapeutic target and biomarker in these disease areas.
References:
1. Shahid, Shifa, Ikeda, Atsushi, Layana, Michelle C, Bartlett, John D. 2022. ADAM10: Possible functions in enamel development. In Frontiers in physiology, 13, 1032383. doi:10.3389/fphys.2022.1032383. https://pubmed.ncbi.nlm.nih.gov/36505044/
2. Lipper, Colin H, Egan, Emily D, Gabriel, Khal-Hentz, Blacklow, Stephen C. 2023. Structural basis for membrane-proximal proteolysis of substrates by ADAM10. In Cell, 186, 3632-3641.e10. doi:10.1016/j.cell.2023.06.026. https://pubmed.ncbi.nlm.nih.gov/37516108/
3. Dorta, Sabrina, Alexandre-Silva, Vanessa, Popolin, Cecilia Patricia, Endres, Kristina, Cominetti, Marcia Regina. 2024. ADAM10 isoforms: Optimizing usage of antibodies based on protein regulation, structural features, biological activity and clinical relevance to Alzheimer's disease. In Ageing research reviews, 101, 102464. doi:10.1016/j.arr.2024.102464. https://pubmed.ncbi.nlm.nih.gov/39173916/
4. Sakamoto, Keiko, Jin, Seon-Pil, Goel, Shubham, Kong, Heidi H, Nagao, Keisuke. 2021. Disruption of the endopeptidase ADAM10-Notch signaling axis leads to skin dysbiosis and innate lymphoid cell-mediated hair follicle destruction. In Immunity, 54, 2321-2337.e10. doi:10.1016/j.immuni.2021.09.001. https://pubmed.ncbi.nlm.nih.gov/34582748/
5. Trerotola, Marco, Guerra, Emanuela, Ali, Zeeshan, Lattanzio, Rossano, Alberti, Saverio. 2021. Trop-2 cleavage by ADAM10 is an activator switch for cancer growth and metastasis. In Neoplasia (New York, N.Y.), 23, 415-428. doi:10.1016/j.neo.2021.03.006. https://pubmed.ncbi.nlm.nih.gov/33839455/
6. Abdalla, Ahmed Me, Miao, Yu, Ming, Ning, Ouyang, Chenxi. 2024. ADAM10 modulates the efficacy of T-cell-mediated therapy in solid tumors. In Immunology and cell biology, 102, 907-923. doi:10.1111/imcb.12826. https://pubmed.ncbi.nlm.nih.gov/39417304/
7. Oliveira Monteiro E Pereira de Almeida, M P, Valle Pedroso, R, Mantellatto Grigoli, M, Manzine, P R, Cominetti, M R. 2023. ADAM10 as a biomarker for Alzheimer's disease: A systematic review. In Revue neurologique, 180, 1-11. doi:10.1016/j.neurol.2023.04.002. https://pubmed.ncbi.nlm.nih.gov/37460331/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
